Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes
| dc.contributor.author | Sanchez-Baltasar, Raquel | |
| dc.contributor.author | Garcia-Torralba, Aida | |
| dc.contributor.author | Nieto-Romero, Virginia | |
| dc.contributor.author | Page, Angustias | |
| dc.contributor.author | Molinos-Vicente, Andrea | |
| dc.contributor.author | López-Manzaneda, Sergio | |
| dc.contributor.author | Ojeda-Pérez, Isabel | |
| dc.contributor.author | Ramírez, Ángel | |
| dc.contributor.author | Navarro, Manuel | |
| dc.contributor.author | Segovia, José Carlos | |
| dc.contributor.author | García-Bravo, María | |
| dc.date.accessioned | 2024-02-06T14:23:34Z | |
| dc.date.available | 2024-02-06T14:23:34Z | |
| dc.date.issued | 2022-06 | |
| dc.description.abstract | Knockout mice for human disease-causing genes provide valuable models in which new therapeutic approaches can be tested. Electroporation of genome editing tools into zygotes, in vitro or within oviducts, allows for the generation of targeted mutations in a shorter time. We have generated mouse models deficient in genes involved in metabolic rare diseases (Primary Hyperoxaluria Type 1 Pyruvate Kinase Deficiency) or in a tumor suppressor gene (Rasa1). Pairs of guide RNAs were designed to generate controlled deletions that led to the absence of protein. In vitro or in vivo ribonucleoprotein (RNP) electroporation rendered more than 90% and 30% edited newborn animals, respectively. Mice lines with edited alleles were established and disease hallmarks have been verified in the three models that showed a high consistency of results and validating RNP electroporation into zygotes as an efficient technique for disease modeling without the need to outsource to external facilities. | es_ES |
| dc.description.sponsorship | This work was supported by grants from “Ministerio de Economía, Comercio y Competitividad” (PID2020-119637RB-I00), Fondo de Investigaciones Sanitarias, “Instituto de Salud Carlos III” (RD21/0017/0027 and PI20/01173), and cofunded by the European Regional Development Fund (FEDER), “Comunidad de Madrid” (AvanCell, B2017/BMD-3692), and Oxalosis and Hyperoxaluria Foundation. The authors also received funds from Instituto de Investigación Sanitaria “Fundación Jiménez Díaz” and CIBERER (CB06/07/0014) and CIBERONC (CB16/12/00228), initiatives of the “Instituto de Salud Carlos III” and “Fondo Europeo de Desarrollo Regional (FEDER).” R.S.-B. is funded by the Consejería de Ciencia, Universidades e Innovación (Comunidad de Madrid), and the European Regional Development Fund (FEDER). “Ministerio de Ciencia, Innovación y Universidades” awarded grants to V.N.-R. (FPU16/02228), A.M.-V. (FPU17/02179), and I.O.-P. (SAF2017-84248-P). | es_ES |
| dc.identifier.citation | Sanchez-Baltasar R, Garcia-Torralba A, Nieto-Romero V, Page A, Molinos-Vicente A, López-Manzaneda S, Ojeda-Pérez I, Ramirez A, Navarro M, Segovia JC, García-Bravo M. Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes. CRISPR J. 2022 Jun;5(3):422-434. doi: 10.1089/crispr.2022.0013. PMID: 35686982; PMCID: PMC9233508. | es_ES |
| dc.identifier.doi | http://dx.doi.org/10.1089/crispr.2022.0013 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14855/2353 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | CRISPR Journal | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.subject | gene editing | es_ES |
| dc.subject | zygotes | es_ES |
| dc.subject | primary hyperoxaluria | es_ES |
| dc.subject | pyruvate kinase deficency | es_ES |
| dc.subject | Rasa1 | es_ES |
| dc.subject | Agxt1 | es_ES |
| dc.subject | Pklr | es_ES |
| dc.subject | mouse models | es_ES |
| dc.title | Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes | es_ES |
| dc.type | journal article | es_ES |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 24. Sanchez-Baltasar- CRISPR J 2022.pdf
- Size:
- 1.09 MB
- Format:
- Adobe Portable Document Format

